Posted by Michael Wonder on 26 Jul 2018
AstraZeneca joins U.S. drug price freeze for rest of 2018
26 July 2018 - AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.S. President Donald Trump over the cost of medicine.
Chief Executive Pascal Soriot said on Thursday the British company had no plans for second-half increases, matching similar commitments from Pfizer, Novartis, Roche and Merck.
“There is a clear commitment in the company to not increase prices in the second half of the year,” he told reporters.
